Scarica l'app Stockscreener
273.07
1.57%
-4.28
Precedente Chiudi:
$277.35
Aprire:
$265.05
Volume 24 ore:
151.84K
Relative Volume:
0.34
Capitalizzazione di mercato:
$10.50B
Reddito:
$1.16B
Utile/perdita netta:
$34.55M
Rapporto P/E:
317.52
EPS:
0.86
Flusso di cassa netto:
$134.18M
1 W Prestazione:
+1.25%
1M Prestazione:
-4.51%
6M Prestazione:
+40.01%
1 anno Prestazione:
+26.98%
Intervallo 1D:
$265.05
$275.46
Intervallo di 1 settimana:
$258.95
$279.79
Portata 52W:
$148.00
$310.00
Penumbra Inc Stock (PEN) Company Profile
Nome
Penumbra Inc
Settore
Industria
Telefono
(510) 995-2486
Indirizzo
ONE PENUMBRA PLACE, ALAMEDA, CA
Confronta PEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
272.91 | 10.50B | 1.16B | 34.55M | 134.18M | 0.86 |
|
ABT
Abbott Laboratories
|
132.06 | 229.74B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
98.88 | 145.53B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
362.76 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.84 | 114.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.97 | 42.24B | 5.72B | 4.17B | 259.90M | 6.97 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-14 | Iniziato | BofA Securities | Buy |
| 2025-01-21 | Iniziato | UBS | Buy |
| 2024-12-17 | Iniziato | Oppenheimer | Outperform |
| 2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | Iniziato | Stifel | Buy |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-31 | Downgrade | Citigroup | Buy → Neutral |
| 2024-07-31 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-29 | Downgrade | Needham | Buy → Hold |
| 2023-01-30 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-10-05 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-09 | Aggiornamento | Needham | Hold → Buy |
| 2022-07-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-04-19 | Iniziato | Deutsche Bank | Buy |
| 2022-03-08 | Iniziato | Needham | Hold |
| 2021-09-16 | Iniziato | Truist | Buy |
| 2021-06-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-07 | Ripresa | Canaccord Genuity | Buy |
| 2020-09-29 | Iniziato | BTIG Research | Buy |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-05-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Iniziato | William Blair | Outperform |
| 2018-10-29 | Ripresa | BofA/Merrill | Buy |
| 2018-10-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-02-21 | Iniziato | William Blair | Outperform |
| 2018-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-13 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Penumbra Inc Borsa (PEN) Ultime notizie
Penumbra director Wilder Thomas sells $95,248 in common stock - Investing.com India
Breakthrough Clinical Data: Penumbra's CAVT Slashes Hospital Stays by 46%, Achieves 99% Success Rate - Stock Titan
Meiji Yasuda Asset Management Co Ltd. Buys New Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
ROSEN, A LEADING LAW FIRM, Encourages Penumbra, Inc. Investors to Secure Counsel Before Important March 16 DeadlinePEN - PR Newswire
Penumbra Insider Sold Shares Worth $3,405,253, According to a Recent SEC Filing - MarketScreener
Penumbra director Arani sells $3.41 million in stock - Investing.com India
Thrombectomy Devices Market Surge: Key Players & Future Outlook - openPR.com
New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues - MSN
Penumbra CEO Adam Elsesser sells $4.59 million in stock By Investing.com - Investing.com Australia
Penumbra CEO Adam Elsesser sells $4.59 million in stock - Investing.com
Do Its Financials Have Any Role To Play In Driving Penumbra, Inc.'s (NYSE:PEN) Stock Up Recently? - Yahoo Finance
Has Penumbra, Inc.'s (NYSE:PEN) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - simplywall.st
Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Peering Into Penumbra's Recent Short Interest - Benzinga
B of A Securities Initiates Coverage of Penumbra (BMV:PEN) with Buy Recommendation - Nasdaq
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Penumbra, Inc. Investors of Important Deadline in Securities Class Action – PEN - Business Wire
Penumbra Inc (PEN) Trading 4.6% Higher on Mar 17 - GuruFocus.com
Penumbra Inc (PEN) Shares Up 4.6% on Mar 15 - GuruFocus.com
Penumbra launched at BofA with Buy on a broad rollout of Flash 2.0 - MSN
What Analysts Are Saying About Penumbra Stock - Benzinga
Penumbra stock launched at BofA with Buy (PEN:NYSE) - Seeking Alpha
B of A Securities Initiates Coverage of Penumbra (PEN) with Buy Recommendation - Nasdaq
Penumbra initiated with a Buy at BofA - TipRanks
Penumbra, Inc. (NYSE:PEN) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Penumbra, Inc. (NYSE:PEN) Given Average Rating of “Moderate Buy” by Analysts - Defense World
Penumbra Off And Running On Renewed Enthusiasm For Mechanical Thrombectomy - Seeking Alpha
Adam Elsesser Sells 61,600 Shares of Penumbra, Inc. (NYSE:PEN) Stock - Defense World
Johanna Roberts Sells 600 Shares of Penumbra, Inc. (NYSE:PEN) Stock - MarketBeat
Penumbra CEO Adam Elsesser sells $17.47 million in stock By Investing.com - Investing.com Canada
Penumbra CEO Adam Elsesser sells $17.47 million in stock - Investing.com
Penumbra director O’Rourke sells $14,274 in stock By Investing.com - Investing.com South Africa
Penumbra director Arani sells $3.45 million in stock By Investing.com - Investing.com South Africa
Penumbra’s Growth Potential Balanced by Market Uncertainties: A Hold Recommendation - TipRanks
Insider Sell: Bridget O'Rourke Sells Shares of Penumbra Inc (PEN) - GuruFocus
Penumbra, Inc. to Host Earnings Call - ACCESS Newswire
Insider Sell: Arani Bose Sells 12,000 Shares of Penumbra Inc (PE - GuruFocus.com
Penumbra director O’Rourke sells $14,274 in stock - Investing.com India
Penumbra EVP Johanna Roberts sells shares worth $172,458 - Investing.com India
Penumbra EVP Johanna Roberts sells shares worth $172,458 By Investing.com - Investing.com South Africa
Penumbra’s chief accounting officer sells shares worth over $2.2 million - Investing.com
Penumbra CFO Maggie Yuen sells $571,994 in stock - Investing.com
Penumbra director Arani sells $3.45 million in stock - Investing.com
Penumbra Announces Board Transition with Kassing’s Retirement - TipRanks
Aspiration-first approaches gather further traction thanks to ‘game-changing’ thrombectomy technologies - NeuroNews International
Penumbra Inc Azioni (PEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.62%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):